cabozantinib,atezolizumab
exelixis,roche
['atezolizumab', '#gu ,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabozantinib', 'urothelial', 'gu ', 'cosmic-021', 'exelixis', 'exelixisinc']
 reveals results from cohorts 3, 4, 5 of the cosmic-021 study. cabozantinib in combination with atezolizumab in #urothelialcarcinoma join at 3:57 pm in arie crown. #asco22 #gu #oncology
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements